Clinical Trials
- Alzheimer's
A Phase 3b/4 Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Verify the Clinical Benefit of Aducanumab (BIIB037) in Participants With Alzheimer's Disease (ENVISION)
- Ages60 years - 85 years
- GenderBoth
- Endocrine System, Genetics
A Phase I/II Study of VTX-801 in Adult Patients With Wilson's Disease (GATEWAY)
- Ages18 years - 60 years
- GenderBoth
- Alzheimer's
AHEAD 3-45 Study: A Study to Evaluate Efficacy and Safety of Treatment With Lecanemab in Participants With Preclinical Alzheimer's Disease and Elevated Amyloid and Also in Participants With Early Preclinical Alzheimer's Disease and Intermediate Amyloid
- Ages55 years - 80 years
- GenderBoth
- Mental Health & Behavioral Research
AMPA Receptor Components of the Anti-Depressant Ketamine Response
- Ages18 years - 65 years
- GenderBoth
- Addictive Behavior
Brain Imaging and Synaptic Plasticity
- Ages21 years - 60 years
- GenderBoth
- Mental Health & Behavioral Research
Eligibility for Participation in Neuroimaging Studies
- Mental Health & Behavioral Research
HPA axis function in the brains of PTSD, Trauma Exposed, or Otherwise Healthy research participants utilizing PET and MRI imaging
- Ages18 years - 55 years
- GenderBoth
- Mental Health & Behavioral Research
Imaging mGluR5 and synaptic density in psychiatric disorders
- Ages18 years - 80 years
- GenderBoth
- Brain, Spinal Cord & Nervous System
Imaging pancreatic beta-cells with PET neuroimaging agent 11C-PHNO
- Ages18 years - 65 years
- GenderBoth
- Addictive Behavior, Mental Health & Behavioral Research, Tobacco Addiction
Imaging smoking-induced dopamine release utilizing PET imaging and nicotine patches
- Ages18 years - 55 years
- GenderBoth